锯齿状息肉病综合征的个体化监测:一项前瞻性5年国际队列研究结果
这项前瞻性国际队列研究纳入271例锯齿状息肉病综合征患者,按息肉负荷制定1年或2年结肠镜监测间隔,中位随访3.6年。监测期间5年结直肠癌累积发生率为1.3%,5年进展期肿瘤发生率为44%;推荐2年间隔者进展期肿瘤风险未增加(OR 0.57,p=0.08);III型患者进展期肿瘤发生率较低。
要点
- 基于息肉负荷的个体化监测方案使多数患者推荐2年间隔,且未增加进展期肿瘤风险。
- 监测期间5年结直肠癌累积发生率为1.3%(95%CI 0%至3.2%)。
- III型患者5年进展期肿瘤发生率26%,低于I型53%及I和III型59%。
核心结论
- 风险分层大幅减少了结肠镜检查负担,同时结直肠癌发生率与既往研究相似。
- 锯齿状息肉病综合征患者进展期肿瘤发生率较高,但按方案判定为低风险者延长监测间隔未增加进展期肿瘤。
- III型患者为低风险组,可能受益于更少频次的监测。
研究设计与样本
- 2013年至2018年在九家荷兰和西班牙医院纳入锯齿状息肉病综合征患者的前瞻性5年国际队列研究。
- 共随访271例患者,中位随访3.6年。
- 每次监测结肠镜后依据息肉负荷制定1年或2年监测间隔。
- 主要终点为监测期间5年结直肠癌和进展期肿瘤的累积发生率。
主要发现
- 监测期间2例发生结直肠癌,5年累积发生率为1.3%(95%CI 0%至3.2%)。
- 5年进展期肿瘤发生率为44%(95%CI 37%至52%)。
- III型患者5年进展期肿瘤发生率为26%,低于I型的53%和I及III型的59%(p<0.001)。
- 多数患者被推荐2年间隔;推荐2年间隔者进展期肿瘤发生率为15.6%,推荐1年间隔者为24.4%(OR 0.57,p=0.08)。
关键数值与推荐
- 国际指南推荐监测间隔为1至2年。
- 本方案依据息肉负荷在每次监测结肠镜后指定1年或2年间隔。
临床怎么用
- 作者认为风险分层可大幅减少结肠镜检查负担,同时结直肠癌发生率与既往研究相似。
- 作者指出按方案判定为低风险者延长监测间隔未增加进展期肿瘤。
- 作者认为III型患者为低风险组,可能受益于更少频次的监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Serrated polyposis syndrome (SPS) is associated with an increased risk of colorectal cancer (CRC). International guidelines recommend surveillance intervals of 1-2 years. However, yearly surveillance likely leads to overtreatment for many. We prospectively assessed a surveillance protocol aiming to safely reduce the burden of colonoscopies. METHODS: Between 2013 and 2018, we enrolled SPS patients from nine Dutch and Spanish hospitals. Patients were surveilled using a protocol appointing either a 1-year or 2-year interval after each surveillance colonoscopy, based on polyp burden. Primary endpoint was the 5-year cumulative incidence of CRC and advanced neoplasia (AN) during surveillance. RESULTS: We followed 271 SPS patients for a median of 3.6 years. During surveillance, two patients developed CRC (cumulative 5-year incidence 1.3%[95% CI 0% to 3.2%]). The 5-year AN incidence was 44% (95% CI 37% to 52%), and was lower for patients with SPS type III (26%) than for patients diagnosed with type I (53%) or type I and III (59%, p<0.001). Most patients were recommended a 2-year interval, and those recommended a 2-year interval were not at increased risk of AN: AN incidence after a 2-year recommendation was 15.6% compared with 24.4% after a 1-year recommendation (OR 0.57, p=0.08). CONCLUSION: Risk stratification substantially reduced colonoscopy burden while achieving CRC incidence similar to previous studies. AN incidence is considerable in SPS patients, but extension of surveillance intervals was not associated with increased AN in those identified as low-risk by the protocol. We identified SPS type III patients as low-risk group that might benefit from even less frequent surveillance. TRIAL REGISTRATION NUMBER: The study was registered on http://www.trialregister.nl; trial-ID NTR4609.
引用
- Bleijenberg AG, IJspeert JE, van Herwaarden YJ, et al. Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study. Gut. 2019. PMID: 30981990. doi:10.1136/gutjnl-2018-318134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。